AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- Cemdisiran, an investigational small interfering RNA (siRNA) therapy targeting complement component 5 (C5), met both its primary and a key secondary endpoint in the phase III NIMBLE trial of generalized myasthenia gravis, whether...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- Suicide by poisoning with the common food preservative sodium nitrite and its oxidised metabolite, nitrate, is disproportionately high among young men, U.K. researchers warned. (BMJ Public Health) Meanwhile, a Canadian man facing...
(MedPage Today) -- SAN DIEGO -- Injecting the PD-1 inhibitor nivolumab (Opdivo) directly into high-risk oral precancers proved safe and reduced lesion size in the vast majority of patients enrolled in a small phase I study, allowing some to avoid...
At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
Watch RFK Jr. testify live before the Senate's health care panel.
